Literature DB >> 21034527

Possible roles of amyloid intracellular domain of amyloid precursor protein.

Keun-A Chang1, Yoo-Hun Suh.   

Abstract

Amyloid precursor protein (APP), which is critically involved in the pathogenesis of Alzheimer's disease (AD), is cleaved by gamma/epsilon-secretase activity and results in the generation of different lengths of the APP Intracellular C-terminal Domain (AICD). In spite of its small size and short half-life, AICD has become the focus of studies on AD pathogenesis. Recently, it was demonstrated that AICD binds to different intracellular binding partners ('adaptor protein'), which regulate its stability and cellular localization. In terms of choice of adaptor protein, phosphorylation seems to play an important role. AICD and its various adaptor proteins are thought to take part in various cellular events, including regulation of gene transcription, apoptosis, calcium signaling, growth factor, and NF-κB pathway activation, as well as the production, trafficking, and processing of APP, and the modulation of cytoskeletal dynamics. This review discusses the possible roles of AICD in the pathogenesis of neurodegenerative diseases including AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034527     DOI: 10.5483/BMBRep.2010.43.10.656

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  18 in total

1.  Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration.

Authors:  Jill S Wentzell; Bonnie J Bolkan; Katia Carmine-Simmen; Tracy L Swanson; Derek T Musashe; Doris Kretzschmar
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

Review 2.  Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.

Authors:  Silke Brunholz; Sangram Sisodia; Alfredo Lorenzo; Carole Deyts; Stefan Kins; Gerardo Morfini
Journal:  Exp Brain Res       Date:  2011-09-30       Impact factor: 1.972

3.  Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.

Authors:  Katalin Völgyi; Krisztina Háden; Viktor Kis; Péter Gulyássy; Kata Badics; Balázs András Györffy; Attila Simor; Zoltán Szabó; Tamás Janáky; László Drahos; Árpád Dobolyi; Botond Penke; Gábor Juhász; Katalin Adrienna Kékesi
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 4.  RIP at the Synapse and the Role of Intracellular Domains in Neurons.

Authors:  Yan Jun Lee; Toh Hean Ch'ng
Journal:  Neuromolecular Med       Date:  2019-07-25       Impact factor: 3.843

Review 5.  Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?

Authors:  Andrew F Teich; Ottavio Arancio
Journal:  Biochem J       Date:  2012-09-01       Impact factor: 3.857

Review 6.  TDP-43: a new player on the AD field?

Authors:  Katherine L Youmans; Benjamin Wolozin
Journal:  Exp Neurol       Date:  2012-06-04       Impact factor: 5.330

Review 7.  Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues.

Authors:  M Obulesu; M Jhansi Lakshmi
Journal:  Neurochem Res       Date:  2014-10-17       Impact factor: 3.996

8.  Purification and aggregation of the amyloid precursor protein intracellular domain.

Authors:  Amina El Ayadi; Emily S Stieren; José M Barral; Andres F Oberhauser; Darren Boehning
Journal:  J Vis Exp       Date:  2012-08-28       Impact factor: 1.355

9.  Oxidative damage and amyloid-β metabolism in brain regions of the longest-lived rodents.

Authors:  Yael H Edrey; Salvatore Oddo; Carolin Cornelius; Antonella Caccamo; Vittorio Calabrese; Rochelle Buffenstein
Journal:  J Neurosci Res       Date:  2013-11-22       Impact factor: 4.164

10.  The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines.

Authors:  David A Hicks; Natalia Z Makova; Mallory Gough; Edward T Parkin; Natalia N Nalivaeva; Anthony J Turner
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.